The R&D Tax Credit has long been one of the most powerful innovation-driven incentives in the tax code. While the core eligibility rules and definitions of qualified research expenses (QREs) have not changed, the reporting landscape has shifted, particularly with the introduction of a detailed Section G on the redesigned Form 6765.

In his latest piece in Forbes, Dave McGuire explores why 2025 will be a pivotal tax planning year. Learn how changes under the OBBBA impact bonus depreciation, Section 174 expensing, and strategic deduction timing for businesses.

As the federal tax landscape continues to shift under the One Big Beautiful Bill Act and its ripple effects, CPAs face a critical moment: how to balance proactive planning with compliance while strengthening their advisory role.

Michigan has decoupled from Section 174A. Learn how new rules require research costs to be amortized and what this means for CPA tax compliance.

Discover how IRS Rev. Proc. 2025-28 impacts Section 174 expensing, 280C elections, and accelerated deductions — key strategies for CPAs and taxpayers.

On October 1, 2025, the IRS announced an extension for certain R&D Tax Credit reporting requirements, giving taxpayers more time to adapt to the revised Form 6765.

Host Dave McGuire sits down with R&D experts David Seibel, EA, and Garrett Duffy to unpack two major developments reshaping R&D credit planning and compliance.

Revenue Procedure 2025-28 provides long-awaited clarity for small businesses on the retroactive Section 174A election, allowing them to deduct 2024 R&E costs on their originally filed return while still amending 2022 and 2023. This guidance simplifies compliance, reduces administrative burden, and gives taxpayers greater certainty in planning for R&D expensing.

“Big Beautiful Bill” aims to reinstate the full expensing of IRC §174 expenditures beginning in 2025. This creates a unique planning opportunity for taxpayers who did not claim the R&D Tax Credit or properly amortize §174 costs during the 2022-2024 tax years.

In his latest piece in Forbes, Dave McGuire explores how the “Big Beautiful Bill” impacts CPAs and their clients, with updates to bonus depreciation, Section 179, and R&D expensing strategies.

David Seibel is a Shareholder for the R&D Tax Credit Practice. He combines his knowledge of tax law with his engineering expertise to maximize companies’ research credits and reduce their overall tax burdens.

David ensures clients are receiving studies that meet the highest level of quality. He conducts fieldwork, produces detailed technical calculations, and builds narratives that accurately reflect each company’s research and experimentation activity.

Recent Resources